Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Vaccination with Lysate-loaded, Mature Dendritic Cells Integrated Into Standard Radiochemotherapy in Newly Diagnosed Glioblastoma

NCT03395587 is registered in ClinicalTrials.gov with Heinrich-Heine University, Duesseldorf as lead sponsor.

NCT NCT03395587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03395587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Vaccination with Lysate-loaded, Mature Dendritic Cells Integrated Into Standard Radiochemotherapy in Newly Diagnosed Glioblastoma
Lead sponsor
Heinrich-Heine University, Duesseldorf
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 6, 2018
Completion date
May 31, 2027
Enrollment
136 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma